SGMS2 and type 2 diabetes mellitus: SMS2 deficiency-mediated reduction of SM in lipid microdomains where insulin receptors located at improved insulin sensitivity, which was responsible for the improvement of obesity and type 2 diabetes (Li et al. 2011; Mitsutake et al. 2011).